Clinical Trial Update: Albumin in Acute Ischemic Stroke Trial [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing albumin in acute ischemic stroke; the study was terminated with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Albumin

Snippet

Sponsor: University of Miami | Conditions: Ischemic Stroke | Phase 3 | Status: TERMINATED | Results posted: 2019-09-11